Jian-Zhou Cao Wei Wu Jin-Feng Pan Hong-Wei Wang Jun-Hui Jiang Qi Ma
10.3389/fonc.2021.643413
Front Oncol
2021 May 24;11:643413.
anlotinib immunotherapy metastatic urothelial bladder carcinoma sintilimab targeted therapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/34109111/
Case Reports
PMC8180869
34109111
Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation
2021